Accessibility Menu
Envoy Medical logo

Envoy Medical

(NASDAQ) COCH

Current Price$0.85
Market Cap$63.56M
Since IPO (2021)-92%
5 YearN/A
1 Year-45%
1 Month+20%

Envoy Medical Financials at a Glance

Market Cap

$63.56M

Revenue (TTM)

$208.00K

Net Income (TTM)

$21.79M

EPS (TTM)

$-1.33

P/E Ratio

-0.62

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.85

Volume

1,690

Open

$0.86

Previous Close

$0.83

Daily Range

$0.85 - $0.88

52-Week Range

$0.36 - $1.91

COCH News

No articles available.

COCH: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Envoy Medical

Industry

Healthcare Equipment and Supplies

Employees

42

CEO

Brent T. Lucas

Headquarters

White Bear Lake, MN 55110, US

COCH Financials

Key Financial Metrics (TTM)

Gross Margin

-3%

Operating Margin

-98%

Net Income Margin

-105%

Return on Equity

0%

Return on Capital

25%

Return on Assets

-3%

Earnings Yield

-1.61%

Dividend Yield

0.00%

Payout Ratio

-11.17%

Stock Overview

Market Cap

$63.56M

Shares Outstanding

76.88M

Volume

1.69K

Short Interest

0.00%

Avg. Volume

745.89K

Financials (TTM)

Gross Profit

$517.00K

Operating Income

$19.26M

EBITDA

$19.81M

Operating Cash Flow

$17.95M

Capital Expenditure

$980.00K

Free Cash Flow

$18.93M

Cash & ST Invst.

$5.48M

Total Debt

$19.66M

Envoy Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$42.00K

-25.0%

Gross Profit

$161.00K

-22.9%

Gross Margin

-3.83%

N/A

Market Cap

$63.56M

N/A

Market Cap/Employee

$1.51M

N/A

Employees

42

N/A

Net Income

$6.48M

-8.8%

EBITDA

$5.93M

-5.1%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$2.61M

+123.3%

Accounts Receivable

$35.00K

-84.7%

Inventory

$1.64M

-0.1%

Long Term Debt

$778.00K

-94.9%

Short Term Debt

$168.00K

-25.3%

Return on Assets

-2.66%

N/A

Return on Invested Capital

25.29%

N/A

Free Cash Flow

$4.33M

-26.6%

Operating Cash Flow

$4.33M

-54.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ATHAAthira Pharma, Inc.
$6.75-6.12%
IRIXIRIDEX Corporation
$1.33-0.75%
ADGMAdagio Medical Holdings, Inc.
$1.05+1.94%
VVOSVivos Therapeutics, Inc.
$1.28+1.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$44.15-0.03%
ANNAAleAnna
$6.98+0.84%
INTCIntel
$45.31-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.56+0.03%

Questions About COCH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.